| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 2,294 | 2,000 | 0.00% | ||
| 2 | ASTERIAS BIOTHERAPEUTICS INC COM SER A | 1,875 | 7,000 | 0.00% | ||
| 3 | CELLADON CORP | 50,000 | 53,000 | 0.01% | ||
| 4 | GERON CORP | 45,000 | 124,000 | 0.02% | ||
| 5 | Theravance Biopharma Inc | 11,428 | 126,000 | 0.02% | ||
| 6 | TETRAPHASE PHARMACEUTICALS INC COM | 22,000 | 164,000 | 0.03% | ||
| 7 | XOMA CORP DEL | 225,000 | 169,000 | 0.03% | ||
| 8 | WRIGHT MEDICAL GROUP NV | 10,000 | 210,000 | 0.03% | ||
| 9 | REWALK ROBOTICS LTD | 30,000 | 229,000 | 0.04% | ||
| 10 | INNOVIVA INC COM | 35,000 | 251,000 | 0.04% | ||
| 11 | DYAX CORP COM CVR | 15,000 | 286,000 | 0.05% | ||
| 12 | IMMUNOGEN INC | 30,000 | 288,000 | 0.05% | ||
| 13 | PENUMBRA INC COM | 10,000 | 401,000 | 0.07% | ||
| 14 | CARDIOVASCULAR SYS INC DEL COM | 30,000 | 475,000 | 0.08% | ||
| 15 | INSULET CORPORATION | 22,500 | 583,000 | 0.10% | ||
| 16 | Juniper Pharmaceuticals Inc | 50,000 | 589,000 | 0.10% | ||
| 17 | ENDOLOGIX INC | 50,000 | 613,000 | 0.10% | ||
| 18 | IMPAX LABORATORIES INC | 18,000 | 634,000 | 0.10% | ||
| 19 | PROTHENA CORP PLC | 15,000 | 680,000 | 0.11% | ||
| 20 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 80,000 | 683,000 | 0.11% | ||
| 21 | ENDOCYTE INC | 158,000 | 724,000 | 0.12% | ||
| 22 | ISHARES TR | 2,500 | 758,000 | 0.12% | ||
| 23 | ARBUTUS BIOPHARMA CORP | 125,000 | 761,000 | 0.12% | ||
| 24 | RESMED INC | 15,000 | 764,000 | 0.12% | ||
| 25 | TEAM HEALTH HOLDINGS INC | 15,000 | 810,000 | 0.13% | ||
| 26 | EXELIXIS INC | 150,000 | 842,000 | 0.14% | ||
| 27 | Esperion Therapeutics Inc | 40,000 | 944,000 | 0.15% | ||
| 28 | MANNKIND CORP. | 300,000 | 963,000 | 0.16% | ||
| 29 | CENTENE CORP DEL | 20,000 | 1,085,000 | 0.18% | ||
| 30 | LABORATORY CORP AMER HLDGS | 10,000 | 1,085,000 | 0.18% | ||
| 31 | INFINITY PHARMACEUTICALS INC | 130,000 | 1,099,000 | 0.18% | ||
| 32 | IKANG HEALTHCARE GROUP INC | 75,000 | 1,110,000 | 0.18% | ||
| 33 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,221,000 | 0.20% | ||
| 34 | MYRIAD GENETICS INC | 33,000 | 1,237,000 | 0.20% | ||
| 35 | ANGIODYNAMICS INC | 100,000 | 1,319,000 | 0.22% | ||
| 36 | JUNO THERAPEUTICS INC COM | 33,000 | 1,343,000 | 0.22% | ||
| 37 | ALDER BIOPHARMACEUTICALS INC | 43,000 | 1,409,000 | 0.23% | ||
| 38 | INTERCEPT PHARMACEUTICALS INCORPORATED | 8,700 | 1,443,000 | 0.24% | ||
| 39 | DAVITA INC | 20,000 | 1,447,000 | 0.24% | ||
| 40 | ABBVIE INC | 27,000 | 1,469,000 | 0.24% | ||
| 41 | INOVIO PHARMACEUTICALS INC | 265,000 | 1,532,000 | 0.25% | ||
| 42 | BAXTER INTL INC | 50,000 | 1,643,000 | 0.27% | ||
| 43 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 1,686,000 | 0.27% | ||
| 44 | WELLCARE HEALTH PLANS INC | 20,000 | 1,724,000 | 0.28% | ||
| 45 | BLUEBIRD BIO INC COM | 20,500 | 1,754,000 | 0.29% | ||
| 46 | MACROGENICS INC | 83,000 | 1,778,000 | 0.29% | ||
| 47 | GLOBUS MED INC | 87,700 | 1,812,000 | 0.30% | ||
| 48 | SEATTLE GENETICS INC | 48,000 | 1,851,000 | 0.30% | ||
| 49 | ACADIA PHARMACEUTICALS INC COM | 59,000 | 1,951,000 | 0.32% | ||
| 50 | Ultra NASDAQ Biotechnology | 35,000 | 2,039,000 | 0.33% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011338, filed 2015.11.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
